A 6-year-old girl with newly diagnosed acute lymphoblastic leukemia (ALL) is being evaluated for risk stratification and prognostic assessment. Her initial WBC count is 12,000/μL, and she achieved complete remission after induction therapy. Which investigation is most important for determining long-term prognosis and guiding intensification of therapy?